TITLE: 장뇌축 동향 — 2026년 10월 11일
This health signal was created by a user. It may contain unverified medical claims. Always consult a qualified healthcare professional before making health decisions.
Gut-brain axis research is rapidly advancing from basic science into large-scale clinical and industrial applications. Backed by ARPA-H, the largest gut-brain-based mental health clinical trial in U.S. history has officially launched, while a recent pharmacological review detailed the mechanisms of interaction between central nervous system drugs and the gut microbiome.
Gut-Brain Axis — 2026-10-11
🔬 Latest Research Highlights
Microbiota–Gut–Brain Axis Interactions with CNS Drugs: A Critical Mechanistic Review of Biopharmaceutical, Pharmacokinetic, and Pharmacodynamic Evidence
- Research Team: MDPI Pharmaceutics (October 2026 issue)
- Key Findings: Systematically reviewed the mechanisms by which the microbiota-gut-brain axis (MGBA) affects the biopharmaceutics, pharmacokinetics (PK), and pharmacodynamics (PD) of central nervous system (CNS) drugs—altering therapeutic efficacy—and conversely, how CNS drugs reshape the MGBA.
- Significance: Provides a foundation for explaining individual differences in psychiatric drug efficacy through the gut microbiome environment, offering important directions for future drug response prediction and personalized treatment strategies.
Gut microbes followed migrating humans across continents, new study suggests
- Research Team: NPR Report (Evolutionary biology/anthropology research)
- Key Findings: Traced how gut flora migrated and adapted alongside humans during continental migrations through a comparative study of gut microbes from Tanzania's hunter-gatherers (Hadza) and Bolivia's horticulturalists (Tsimane).
- Significance: Suggests that the gut microbiome composition of modern humans is deeply linked to evolutionary migration history rather than diet alone, highlighting the need to develop region-specific tailored probiotics.
💊 Clinical Trials & Therapeutics Trends
- GUT-FEELINGS Program: Co-led by Holobiome and Radicle Science with funding from ARPA-H (Advanced Research Projects Agency for Health), this initiative has launched the largest gut-brain axis-based mental health clinical trial in U.S. history, involving over 6,000 participants. The goal is to identify over-the-counter, non-pharmaceutical solutions.
🏢 Industry & Business
- Holobiome & Radicle Science: Through the GUT-FEELINGS program, they plan to generate unprecedented interventional data to map correlations between gut microbiome data and mental health indicators. This is expected to accelerate the commercialization and standardization of gut-brain axis technology.
🧠 Deep Dive: The 'Two-Way' Conversation Between CNS Drugs and Gut Microbes
A recently published review paper clarified that the relationship between central nervous system (CNS) drugs and the microbiota-gut-brain axis (MGBA) is a two-way street rather than a one-way path. While gut microbes were previously viewed merely as auxiliary aids helping drug absorption or metabolism, it has now been revealed that actual antidepressants and antipsychotics can alter gut barrier permeability and disrupt microbial diversity, indirectly impacting brain function.
This process is primarily mediated by changes in the secretion of short-chain fatty acids (SCFAs) or neurotransmitter precursors (such as serotonin) produced by microbes. When drugs suppress specific beneficial bacteria, SCFA production drops, weakening the blood-brain barrier (BBB) and leading to reduced drug efficacy or increased side effects. Conversely, creating a healthy gut environment raises the possibility of achieving the same effects at lower drug doses or mitigating side effects. Uncovering this mechanism will become core to a new precision medicine paradigm that accounts for 'Drug-Microbiome Interactions.'
📋 Action Guide
- Consider Probiotics with Antibiotics: Just as CNS drugs can disturb gut microbes, antibiotics exert similar effects. Taking beneficial bacteria supplements during treatment helps maintain MGBA balance and protects brain health.
- Secure Natural Microbial Diversity via Fermented Foods: Evolutionarily, gut microbes have adapted according to diet. Consistently consume traditional fermented foods like kimchi, doenjang, and kefir instead of processed foods to enhance the resilience of your gut ecosystem.
- Include Gut Health Metrics in Mental Health Management: Much like the GUT-FEELINGS study suggests, gut microbes and mental states are tightly connected. If anxiety or depression persists, try a holistic approach that combines psychological counseling with gut health diagnostics.
👀 Key Points to Watch
- ARPA-H GUT-FEELINGS Interim Results Release: Anticipating specific outcomes regarding the effectiveness of non-pharmaceutical gut-brain axis solutions as the large-scale data analysis of 6,000 participants concludes.
- Discussions on Revising CNS Drug Prescription Guidelines: As research on drug-microbiome interactions accumulates, whether the FDA and global regulatory agencies will include microbiome-related warnings or dietary recommendations on drug labels.
- Expansion of the Personalized Probiotics Market: The launch of customized probiotic products reflecting evolutionary backgrounds and individual gut microbiome compositions is expected to pick up pace.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
